keyword：ONTORES was invited to the EPS conference and it was a great success!
The 35th European Peptide Symposiumconcluded successfully in Dublin, the capital of Ireland, August 26-31, 2018.Speakers at the conference included BeateKoksch fromFree University of Berlin,David r. Spring fromUniversity of Cambridge and many other known experts in thefield of peptide drug research.
35EPS Session Topics
Amino acids and peptide synthesis
Protein synthesis and semi-synthesis
Peptides in chemical biology andtherapeutics
Structural and conformational studies
Biologically active peptides
Prodrugs, conjugates, targeting and uptake
Peptide in proteomics and bioinformatics
Nanotechnology, imaging and analyticaltechniques
Peptide-based materials and catalysis
Glycopeptides and lipopeptides
Biochemistry and biology
ONTORES has been engaged in EPS conferencefor many years and has gained a certain popularity and good reputation inEuropean market. At this meeting, many key customers from Europe came toONTORES booth and had extensive and in-depth communication on business with us.In addition, more than 100 new customers came to our booth and showed interestin our products and services.
The exhibition scene The exhibition scene
Chandralal Hewage visited ONTORES booth Group photo with customer
Our booth was welcomed by the customer Our booth was welcomed by the customer
Founded in 2009, ONTORES BIOTECHNOLOGIES isa world leading biotechnology company. We are committed to providingprofessional high quality peptide products and peptide customized services forglobal customers. The ONTORES platform provides integrated solutions for thedevelopment of polypeptide drug technologies, from technology development tosmall and pilot trials of clinical pharmaceutical products and commercial scaledrug production needs, helping our partners realize the unlimited possibilityof exploring new drugs.